nr |
titel |
type |
1 |
Cardiovascular drugs and therapy, vol. 29, no. 1 (2015)
|
aflevering |
2 |
Cardiovascular drugs and therapy, vol. 26, no. 1 (2011)
|
aflevering |
3 |
Cardiovascular drugs and therapy, vol. 31, no. 1 (2016)
|
aflevering |
4 |
Cardiovascular drugs and therapy, vol. 32, no. 1 (2018)
|
aflevering |
5 |
Cardiovascular drugs and therapy, vol. 21, no. 1 (2007)
|
aflevering |
6 |
Cardiovascular drugs and therapy, vol. 16, no. 1 (2001)
|
aflevering |
7 |
Cardiovascular drugs and therapy, vol. 30, no. 1 (2016)
|
aflevering |
8 |
Cardiovascular drugs and therapy, vol. 25, no. 1 (2011)
|
aflevering |
9 |
Cardiovascular drugs and therapy, vol. 27, no. 1 (2013)
|
aflevering |
10 |
Cardiovascular drugs and therapy, vol. 28, no. 1 (2013)
|
aflevering |
11 |
Cardiovascular drugs and therapy, vol. 23, no. 1 (2008)
|
aflevering |
12 |
Cardiovascular drugs and therapy, vol. 33, no. 1 (2019)
|
aflevering |
13 |
Cardiovascular drugs and therapy, vol. 36, no. 1 (2021-1-5)
|
aflevering |
14 |
Cardiovascular drugs and therapy, vol. 14, no. 1 (2000-02)
|
aflevering |
15 |
Cardiovascular drugs and therapy, vol. 16, no. 1 (2002-01)
|
aflevering |
16 |
Cardiovascular drugs and therapy, vol. 12, no. 1 (1998-04)
|
aflevering |
17 |
Cardiovascular drugs and therapy, vol. 18, no. 1 (2004)
|
aflevering |
18 |
Cardiovascular drugs and therapy, vol. 13, no. 1 (1999-03)
|
aflevering |
19 |
Cardiovascular drugs and therapy, vol. 20, no. 1 (2006)
|
aflevering |
20 |
Cardiovascular drugs and therapy, vol. 15, no. 1 (2001-01)
|
aflevering |
21 |
Cardiovascular drugs and therapy, vol. 18, no. 1 (2004-01)
|
aflevering |
22 |
Cardiovascular drugs and therapy, vol. 17, no. 1 (2003-01)
|
aflevering |
23 |
Cardiovascular drugs and therapy, vol. 11, no. 1 (1997-05)
|
aflevering |
24 |
Cardiovascular drugs and therapy, vol. 22, no. 1 (2008)
|
aflevering |
25 |
Cardiovascular drugs and therapy, vol. 24, no. 1 (2010)
|
aflevering |
26 |
Cardiovascular drugs and therapy, vol. 12, no. 1 (1998)
|
aflevering |
27 |
Cardiovascular drugs and therapy, vol. 15, no. 1 (2001)
|
aflevering |
28 |
Cardiovascular drugs and therapy, vol. 17, no. 1 (2003)
|
aflevering |
29 |
Cardiovascular drugs and therapy, vol. 18, no. 1 (2004)
|
aflevering |
30 |
Cardiovascular drugs and therapy, vol. 14, no. 1 (2000)
|
aflevering |
31 |
Cardiovascular drugs and therapy, vol. 11, no. 1 (1997)
|
aflevering |
32 |
Cardiovascular drugs and therapy, vol. 13, no. 1 (1999)
|
aflevering |
33 |
Cardiovascular drugs and therapy, vol. 35, no. 1 (2020-6-9)
|
aflevering |
34 |
Cardiovascular drugs and therapy, vol. 23, no. 1 (2008-10-14)
|
aflevering |
35 |
Cardiovascular drugs and therapy, vol. 26, no. 1 (2011-11-24)
|
aflevering |
36 |
Cardiovascular drugs and therapy, vol. 34, no. 1 (2020-2-20)
|
aflevering |
37 |
Cardiovascular drugs and therapy, vol. 19, no. 1 (2005-1-1)
|
aflevering |
38 |
Cardiovascular drugs and therapy, vol. 30, no. 1 (2016-2-5)
|
aflevering |
39 |
Cardiovascular drugs and therapy, vol. 38, no. 1 (2024-2-6)
|
aflevering |
40 |
Cardiovascular drugs and therapy, vol. 37, no. 1 (2021-10-11)
|
aflevering |
41 |
Cardiovascular drugs and therapy, vol. 39, no. 1 (2024-11-13)
|
aflevering |
42 |
Cardiovascular drugs and therapy, vol. 34, no. 14 (2001)
|
aflevering |
43 |
Cardiovascular drugs and therapy, vol. 25, no. 2 (2011)
|
aflevering |
44 |
Cardiovascular drugs and therapy, vol. 24, no. 2 (2010)
|
aflevering |
45 |
Cardiovascular drugs and therapy, vol. 26, no. 2 (2012)
|
aflevering |
46 |
Cardiovascular drugs and therapy, vol. 28, no. 2 (2014)
|
aflevering |
47 |
Cardiovascular drugs and therapy, vol. 31, no. 2 (2017)
|
aflevering |
48 |
Cardiovascular drugs and therapy, vol. 21, no. 2 (2007-5-8)
|
aflevering |
49 |
Cardiovascular drugs and therapy, vol. 32, no. 2 (2018)
|
aflevering |
50 |
Cardiovascular drugs and therapy, vol. 29, no. 2 (2015)
|
aflevering |
51 |
Cardiovascular drugs and therapy, vol. 30, no. 2 (2016)
|
aflevering |
52 |
Cardiovascular drugs and therapy, vol. 27, no. 2 (2013)
|
aflevering |
53 |
Cardiovascular drugs and therapy, vol. 33, no. 2 (2019)
|
aflevering |
54 |
Cardiovascular drugs and therapy, vol. 35, no. 2 (2021-3-13)
|
aflevering |
55 |
Cardiovascular drugs and therapy, vol. 36, no. 2 (2022-2-26)
|
aflevering |
56 |
Cardiovascular drugs and therapy, vol. 14, no. 2 (2000-03)
|
aflevering |
57 |
Cardiovascular drugs and therapy, vol. 19, no. 2 (2005)
|
aflevering |
58 |
Cardiovascular drugs and therapy, vol. 11, no. 2 (1997-06)
|
aflevering |
59 |
Cardiovascular drugs and therapy, vol. 12, no. 2 (1998-05)
|
aflevering |
60 |
Cardiovascular drugs and therapy, vol. 16, no. 2 (2002-03)
|
aflevering |
61 |
Cardiovascular drugs and therapy, vol. 13, no. 2 (1999-04)
|
aflevering |
62 |
Cardiovascular drugs and therapy, vol. 15, no. 2 (2001-03)
|
aflevering |
63 |
Cardiovascular drugs and therapy, vol. 17, no. 2 (2003-03)
|
aflevering |
64 |
Cardiovascular drugs and therapy, vol. 18, no. 2 (2004-03)
|
aflevering |
65 |
Cardiovascular drugs and therapy, vol. 20, no. 2 (2006)
|
aflevering |
66 |
Cardiovascular drugs and therapy, vol. 22, no. 2 (2008)
|
aflevering |
67 |
Cardiovascular drugs and therapy, vol. 18, no. 2 (2004)
|
aflevering |
68 |
Cardiovascular drugs and therapy, vol. 23, no. 2 (2009)
|
aflevering |
69 |
Cardiovascular drugs and therapy, vol. 14, no. 2 (2000)
|
aflevering |
70 |
Cardiovascular drugs and therapy, vol. 13, no. 2 (1999)
|
aflevering |
71 |
Cardiovascular drugs and therapy, vol. 11, no. 2 (1997)
|
aflevering |
72 |
Cardiovascular drugs and therapy, vol. 12, no. 2 (1998)
|
aflevering |
73 |
Cardiovascular drugs and therapy, vol. 15, no. 2 (2001)
|
aflevering |
74 |
Cardiovascular drugs and therapy, vol. 16, no. 2 (2002)
|
aflevering |
75 |
Cardiovascular drugs and therapy, vol. 17, no. 2 (2003)
|
aflevering |
76 |
Cardiovascular drugs and therapy, vol. 21, no. 2 (2007)
|
aflevering |
77 |
Cardiovascular drugs and therapy, vol. 34, no. 2 (2020-3-10)
|
aflevering |
78 |
Cardiovascular drugs and therapy, vol. 37, no. 2 (2022-11-15)
|
aflevering |
79 |
Cardiovascular drugs and therapy, vol. 38, no. 2 (2024-2-6)
|
aflevering |
80 |
Cardiovascular drugs and therapy, vol. 25, no. 3 (2011)
|
aflevering |
81 |
Cardiovascular drugs and therapy, vol. 24, no. 3 (2010)
|
aflevering |
82 |
Cardiovascular drugs and therapy, vol. 23, no. 3 (2009)
|
aflevering |
83 |
Cardiovascular drugs and therapy, vol. 22, no. 3 (2008)
|
aflevering |
84 |
Cardiovascular drugs and therapy, vol. 26, no. 3 (2012)
|
aflevering |
85 |
Cardiovascular drugs and therapy, vol. 28, no. 3 (2014)
|
aflevering |
86 |
Cardiovascular drugs and therapy, vol. 21, no. 3 (2007-5-17)
|
aflevering |
87 |
Cardiovascular drugs and therapy, vol. 36, no. 3 (2022-2-14)
|
aflevering |
88 |
Cardiovascular drugs and therapy, vol. 34, no. 3 (2020-3-24)
|
aflevering |
89 |
Cardiovascular drugs and therapy, vol. 31, no. 3 (2017)
|
aflevering |
90 |
Cardiovascular drugs and therapy, vol. 32, no. 3 (2018)
|
aflevering |
91 |
Cardiovascular drugs and therapy, vol. 29, no. 3 (2015)
|
aflevering |
92 |
Cardiovascular drugs and therapy, vol. 30, no. 3 (2016)
|
aflevering |
93 |
Cardiovascular drugs and therapy, vol. 27, no. 3 (2013)
|
aflevering |
94 |
Cardiovascular drugs and therapy, vol. 33, no. 3 (2019)
|
aflevering |
95 |
Cardiovascular drugs and therapy, vol. 23, no. 3 (2009-5-7)
|
aflevering |
96 |
Cardiovascular drugs and therapy, vol. 14, no. 3 (2000-03)
|
aflevering |
97 |
Cardiovascular drugs and therapy, vol. 16, no. 3 (2002-05)
|
aflevering |
98 |
Cardiovascular drugs and therapy, vol. 19, no. 3 (2005)
|
aflevering |
99 |
Cardiovascular drugs and therapy, vol. 12, no. 3 (1998-10)
|
aflevering |
100 |
Cardiovascular drugs and therapy, vol. 13, no. 3 (1999-05)
|
aflevering |
101 |
Cardiovascular drugs and therapy, vol. 18, no. 3 (2004-05)
|
aflevering |
102 |
Cardiovascular drugs and therapy, vol. 17, no. 3 (2003-05)
|
aflevering |
103 |
Cardiovascular drugs and therapy, vol. 15, no. 3 (2001-05)
|
aflevering |
104 |
Cardiovascular drugs and therapy, vol. 11, no. 3 (1997-07)
|
aflevering |
105 |
Cardiovascular drugs and therapy, vol. 20, no. 3 (2006)
|
aflevering |
106 |
Cardiovascular drugs and therapy, vol. 14, no. 3 (2000)
|
aflevering |
107 |
Cardiovascular drugs and therapy, vol. 15, no. 3 (2001)
|
aflevering |
108 |
Cardiovascular drugs and therapy, vol. 17, no. 3 (2003)
|
aflevering |
109 |
Cardiovascular drugs and therapy, vol. 18, no. 3 (2004)
|
aflevering |
110 |
Cardiovascular drugs and therapy, vol. 11, no. 3 (1997)
|
aflevering |
111 |
Cardiovascular drugs and therapy, vol. 12, no. 3 (1998)
|
aflevering |
112 |
Cardiovascular drugs and therapy, vol. 16, no. 3 (2002)
|
aflevering |
113 |
Cardiovascular drugs and therapy, vol. 13, no. 3 (1999)
|
aflevering |
114 |
Cardiovascular drugs and therapy, vol. 21, no. 3 (2007)
|
aflevering |
115 |
Cardiovascular drugs and therapy, vol. 27, no. 3 (2013-2-10)
|
aflevering |
116 |
Cardiovascular drugs and therapy, vol. 37, no. 3 (2023-3-28)
|
aflevering |
117 |
Cardiovascular drugs and therapy, vol. 35, no. 3 (2020-11-6)
|
aflevering |
118 |
Cardiovascular drugs and therapy, vol. 38, no. 3 (2024-3-23)
|
aflevering |
119 |
Cardiovascular drugs and therapy, vol. 25, no. 4 (2011)
|
aflevering |
120 |
Cardiovascular drugs and therapy, vol. 24, no. 4 (2010)
|
aflevering |
121 |
Cardiovascular drugs and therapy, vol. 23, no. 4 (2009)
|
aflevering |
122 |
Cardiovascular drugs and therapy, vol. 19, no. 4 (2005)
|
aflevering |
123 |
Cardiovascular drugs and therapy, vol. 22, no. 4 (2008)
|
aflevering |
124 |
Cardiovascular drugs and therapy, vol. 26, no. 4 (2012)
|
aflevering |
125 |
Cardiovascular drugs and therapy, vol. 28, no. 4 (2014)
|
aflevering |
126 |
Cardiovascular drugs and therapy, vol. 19, no. 4 (2005-9-20)
|
aflevering |
127 |
Cardiovascular drugs and therapy, vol. 36, no. 4 (2021-5-14)
|
aflevering |
128 |
Cardiovascular drugs and therapy, vol. 32, no. 4 (2018)
|
aflevering |
129 |
Cardiovascular drugs and therapy, vol. 30, no. 4 (2016)
|
aflevering |
130 |
Cardiovascular drugs and therapy, vol. 29, no. 4 (2015)
|
aflevering |
131 |
Cardiovascular drugs and therapy, vol. 27, no. 4 (2013)
|
aflevering |
132 |
Cardiovascular drugs and therapy, vol. 31, no. 4 (2017)
|
aflevering |
133 |
Cardiovascular drugs and therapy, vol. 33, no. 4 (2019)
|
aflevering |
134 |
Cardiovascular drugs and therapy, vol. 35, no. 4 (2021-5-31)
|
aflevering |
135 |
Cardiovascular drugs and therapy, vol. 14, no. 4 (2000-06)
|
aflevering |
136 |
Cardiovascular drugs and therapy, vol. 16, no. 4 (2002-07)
|
aflevering |
137 |
Cardiovascular drugs and therapy, vol. 12, no. 4 (1998-09)
|
aflevering |
138 |
Cardiovascular drugs and therapy, vol. 13, no. 4 (1999-07)
|
aflevering |
139 |
Cardiovascular drugs and therapy, vol. 15, no. 4 (2001-07)
|
aflevering |
140 |
Cardiovascular drugs and therapy, vol. 18, no. 4 (2004-07)
|
aflevering |
141 |
Cardiovascular drugs and therapy, vol. 17, no. 4 (2003-07)
|
aflevering |
142 |
Cardiovascular drugs and therapy, vol. 11, no. 4 (1997)
|
aflevering |
143 |
Cardiovascular drugs and therapy, vol. 21, no. 4 (2007)
|
aflevering |
144 |
Cardiovascular drugs and therapy, vol. 15, no. 4 (2001)
|
aflevering |
145 |
Cardiovascular drugs and therapy, vol. 11, no. 4 (1997)
|
aflevering |
146 |
Cardiovascular drugs and therapy, vol. 16, no. 4 (2002)
|
aflevering |
147 |
Cardiovascular drugs and therapy, vol. 17, no. 4 (2003)
|
aflevering |
148 |
Cardiovascular drugs and therapy, vol. 20, no. 4 (2006)
|
aflevering |
149 |
Cardiovascular drugs and therapy, vol. 12, no. 4 (1998)
|
aflevering |
150 |
Cardiovascular drugs and therapy, vol. 13, no. 4 (1999)
|
aflevering |
151 |
Cardiovascular drugs and therapy, vol. 14, no. 4 (2000)
|
aflevering |
152 |
Cardiovascular drugs and therapy, vol. 18, no. 4 (2004)
|
aflevering |
153 |
Cardiovascular drugs and therapy, vol. 32, no. 4 (2018-8-7)
|
aflevering |
154 |
Cardiovascular drugs and therapy, vol. 34, no. 4 (2020-5-11)
|
aflevering |
155 |
Cardiovascular drugs and therapy, vol. 37, no. 4 (2022-2-17)
|
aflevering |
156 |
Cardiovascular drugs and therapy, vol. 38, no. 4 (2024-6-18)
|
aflevering |
157 |
Cardiovascular drugs and therapy, vol. 25, no. 5 (2011)
|
aflevering |
158 |
Cardiovascular drugs and therapy, vol. 21, no. 5 (2007)
|
aflevering |
159 |
Cardiovascular drugs and therapy, vol. 36, no. 5 (2022-7-6)
|
aflevering |
160 |
Cardiovascular drugs and therapy, vol. 28, no. 5 (2014)
|
aflevering |
161 |
Cardiovascular drugs and therapy, vol. 29, no. 5 (2015)
|
aflevering |
162 |
Cardiovascular drugs and therapy, vol. 30, no. 5 (2016)
|
aflevering |
163 |
Cardiovascular drugs and therapy, vol. 27, no. 5 (2013)
|
aflevering |
164 |
Cardiovascular drugs and therapy, vol. 22, no. 5 (2008)
|
aflevering |
165 |
Cardiovascular drugs and therapy, vol. 26, no. 5 (2012)
|
aflevering |
166 |
Cardiovascular drugs and therapy, vol. 32, no. 5 (2018)
|
aflevering |
167 |
Cardiovascular drugs and therapy, vol. 33, no. 5 (2019)
|
aflevering |
168 |
Cardiovascular drugs and therapy, vol. 35, no. 5 (2021-6-8)
|
aflevering |
169 |
Cardiovascular drugs and therapy, vol. 13, no. 5 (1999-09)
|
aflevering |
170 |
Cardiovascular drugs and therapy, vol. 18, no. 5 (2005)
|
aflevering |
171 |
Cardiovascular drugs and therapy, vol. 14, no. 5 (2000-10)
|
aflevering |
172 |
Cardiovascular drugs and therapy, vol. 16, no. 5 (2002-09)
|
aflevering |
173 |
Cardiovascular drugs and therapy, vol. 19, no. 5 (2005)
|
aflevering |
174 |
Cardiovascular drugs and therapy, vol. 12, no. 5 (1998-09)
|
aflevering |
175 |
Cardiovascular drugs and therapy, vol. 15, no. 5 (2001-09)
|
aflevering |
176 |
Cardiovascular drugs and therapy, vol. 17, no. 5 (2003-09/11-/11)
|
aflevering |
177 |
Cardiovascular drugs and therapy, vol. 11, no. 5 (1997)
|
aflevering |
178 |
Cardiovascular drugs and therapy, vol. 23, no. 5 (2009)
|
aflevering |
179 |
Cardiovascular drugs and therapy, vol. 15, no. 5 (2001)
|
aflevering |
180 |
Cardiovascular drugs and therapy, vol. 16, no. 5 (2002)
|
aflevering |
181 |
Cardiovascular drugs and therapy, vol. 18, no. 5 (2004)
|
aflevering |
182 |
Cardiovascular drugs and therapy, vol. 11, no. 5 (1997)
|
aflevering |
183 |
Cardiovascular drugs and therapy, vol. 12, no. 5 (1998)
|
aflevering |
184 |
Cardiovascular drugs and therapy, vol. 13, no. 5 (1999)
|
aflevering |
185 |
Cardiovascular drugs and therapy, vol. 20, no. 5 (2006)
|
aflevering |
186 |
Cardiovascular drugs and therapy, vol. 14, no. 5 (2000)
|
aflevering |
187 |
Cardiovascular drugs and therapy, vol. 29, no. 5 (2015-7-7)
|
aflevering |
188 |
Cardiovascular drugs and therapy, vol. 34, no. 5 (2020-6-20)
|
aflevering |
189 |
Cardiovascular drugs and therapy, vol. 25, no. 5 (2011-8-23)
|
aflevering |
190 |
Cardiovascular drugs and therapy, vol. 32, no. 5 (2018-8-31)
|
aflevering |
191 |
Cardiovascular drugs and therapy, vol. 37, no. 5 (2023-9-13)
|
aflevering |
192 |
Cardiovascular drugs and therapy, vol. 38, no. 5 (2024-9-5)
|
aflevering |
193 |
Cardiovascular drugs and therapy, vol. 24, no. 5-6 (2010)
|
aflevering |
194 |
Cardiovascular drugs and therapy, vol. 31, no. 5-6 (2017)
|
aflevering |
195 |
Cardiovascular drugs and therapy, vol. 17, no. 5-6 (2003)
|
aflevering |
196 |
Cardiovascular drugs and therapy, vol. 25, no. 6 (2011)
|
aflevering |
197 |
Cardiovascular drugs and therapy, vol. 30, no. 6 (2016)
|
aflevering |
198 |
Cardiovascular drugs and therapy, vol. 21, no. 6 (2007-11-10)
|
aflevering |
199 |
Cardiovascular drugs and therapy, vol. 36, no. 6 (2022-10-22)
|
aflevering |
200 |
Cardiovascular drugs and therapy, vol. 29, no. 6 (2015)
|
aflevering |
201 |
Cardiovascular drugs and therapy, vol. 27, no. 6 (2013)
|
aflevering |
202 |
Cardiovascular drugs and therapy, vol. 22, no. 6 (2008)
|
aflevering |
203 |
Cardiovascular drugs and therapy, vol. 26, no. 6 (2012)
|
aflevering |
204 |
Cardiovascular drugs and therapy, vol. 28, no. 6 (2014)
|
aflevering |
205 |
Cardiovascular drugs and therapy, vol. 32, no. 6 (2018)
|
aflevering |
206 |
Cardiovascular drugs and therapy, vol. 35, no. 6 (2021-9-7)
|
aflevering |
207 |
Cardiovascular drugs and therapy, vol. 14, no. 6 (2000-12)
|
aflevering |
208 |
Cardiovascular drugs and therapy, vol. 16, no. 6 (2002-12)
|
aflevering |
209 |
Cardiovascular drugs and therapy, vol. 13, no. 6 (1999-11)
|
aflevering |
210 |
Cardiovascular drugs and therapy, vol. 12, no. 6 (1998-12)
|
aflevering |
211 |
Cardiovascular drugs and therapy, vol. 15, no. 6 (2001-11)
|
aflevering |
212 |
Cardiovascular drugs and therapy, vol. 11, no. 6 (1997-12)
|
aflevering |
213 |
Cardiovascular drugs and therapy, vol. 19, no. 6 (2006)
|
aflevering |
214 |
Cardiovascular drugs and therapy, vol. 21, no. 6 (2007)
|
aflevering |
215 |
Cardiovascular drugs and therapy, vol. 23, no. 6 (2009)
|
aflevering |
216 |
Cardiovascular drugs and therapy, vol. 18, no. 6 (2004)
|
aflevering |
217 |
Cardiovascular drugs and therapy, vol. 11, no. 6 (1997)
|
aflevering |
218 |
Cardiovascular drugs and therapy, vol. 15, no. 6 (2001)
|
aflevering |
219 |
Cardiovascular drugs and therapy, vol. 16, no. 6 (2002)
|
aflevering |
220 |
Cardiovascular drugs and therapy, vol. 13, no. 6 (1999)
|
aflevering |
221 |
Cardiovascular drugs and therapy, vol. 12, no. 6 (1998)
|
aflevering |
222 |
Cardiovascular drugs and therapy, vol. 14, no. 6 (2000)
|
aflevering |
223 |
Cardiovascular drugs and therapy, vol. 20, no. 6 (2006)
|
aflevering |
224 |
Cardiovascular drugs and therapy, vol. 34, no. 6 (2020-8-8)
|
aflevering |
225 |
Cardiovascular drugs and therapy, vol. 33, no. 6 (2019-10-25)
|
aflevering |
226 |
Cardiovascular drugs and therapy, vol. 37, no. 6 (2023-7-14)
|
aflevering |
227 |
Cardiovascular drugs and therapy, vol. 38, no. 6 (2024-8-8)
|
aflevering |
228 |
Cardiovascular drugs and therapy, vol. 16, no. Supplement? (2002-05)
|
aflevering |
229 |
Cardiovascular drugs and therapy, vol. 18, no. Supplement? (2004)
|
aflevering |
230 |
Cardiovascular drugs and therapy, vol. 15, no. Supplement? (2001-03)
|
aflevering |
231 |
Cardiovascular drugs and therapy, vol. 25, no. supplement-1 (2011)
|
aflevering |